Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2018.463 | Gut microbiota and Hepatocellular carcinoma | Prof. YU Jun |
| 2019.132 | A study of the clinical significance and molecular mechanism of TRIP6 in colorectal cancer invasion and metastasis. |
Prof. YU Jun 于君 |
| 2020.024 | Elucidating the role of gut microbial dysbiosis in colorectal cancer |
Prof. YU Jun 于君 |
| 2018.058 | Dissecting the role of SQLE which links aberrant cholesterol mechanism to the induction of Non-alcoholic fatty liver disease |
Prof. YU Jun 于君 |
| 2018.359 | Centre for Gut Microbiome in Cancers |
Prof. YU Jun 于君 |
| 2019.425 | Exploiting epitranscriptome dysregulation in colorectal carcinogenesis and metastasis: mechanisms and novel therapeutic approaches |
Prof. YU Jun 于君 |
| 2022.025 | Modulation of antitumor immune response by gut microbiota: characterization, molecular mechanism and translational value |
Prof. YU Jun 于君 |
| 2022.108 | RNA m6A甲基化识别蛋白YTHDF1在调控结直肠癌免疫微环境中的作用及机制研究 (Elucidating the role and mechanism of RNA m6A reader YTHDF1 in regulating the immune microenvironment of colorectal cancer) |
Prof. YU Jun 于君 |
| 2022.026 | RNA N6-Methyladenosine (m6A) Methyltransferase METTL3 facilitates non-alcoholic fatty liver disease-associated hepatocellular carcinoma (NAFLDHCC) via a m6A-cholesterol axis to repress T-cell function |
Prof. YU Jun 于君 |
| 2021.451 | Developing probiotics into high-efficacy and safe prophylactics and adjuvant therapies for colorectal cancer |
Prof. YU Jun 于君 |
| 2023.022 | RNA N6-Methyladenosine Demethylase AlkB Homolog 5 (ALKBH5) promotes stemness and chemoresistance in colorectal cancer: mechanism and novel therapeutic approaches |
Prof. YU Jun 于君 |
| 2023.457 | Targeting m6A modification to boost chemotherapy and immunotherapy efficacy in colorectal cancer |
Prof. YU Jun 于君 |
| 2023.016 | Microbiota in Gastrointestinal Cancers: Mechanistic Investigation and Clinical Applications |
Prof. YU Jun 于君 |
| 2022.203 | Altered gut microbiome composition by appendectomy contributes to colorectal cancer |
Prof. YU Jun 于君 |
| 2023.017 | Deciphering the role of gut microbiota in modulating antitumor immune response in colorectal cancer: mechanisms and translational value |
Prof. YU Jun 于君 |
| 2023.114 | RNA m6A去甲基化酶ALKBH5对结直肠癌化疗疗效的影响及作用机制 (Targeting RNA m6A eraser ALKBH5 boosts the efficacy of chemotherapy in colorectal cancer) |
Prof. YU Jun 于君 |
| 2020.685 | Deciphering the role and molecular mechanisms of predominant bacterial pathogens in colorectal cancer pathogenesis and augment therapies |
Prof. YU Jun 于君 |
| 2023.631 | Targeting Cancer Stem Cells in Non-alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications |
Prof. YU Jun 于君 |
| 2020.684 | RNA Demethylase AlkB Homolog 5 (ALKBH5) drives immune suppression in colorectal cancer via epitranscriptome regulation of AXIN2-WNT-DKK1 axis |
Prof. YU Jun 于君 |
| 2024.570 | Faecalibacterium prausnitzii potentiates chemotherapy response in colorectal cancer: molecular mechanisms and translational implications | Prof. YU Jun |
| 2013.481 | Pilot study on the effect of hearing aid use on the change of cognitive function on elderly with hearing impairment | Dr. Yu Joannie Ka Yin |
| 2022.322 | The effectiveness of patient navigator intervention in promoting the uptake of colorectal cancer screening for the average risk older adults in Hong Kong: A pilot study |
Ms. YU Hoi Un 余海鶯 |
| 2021.383 | Creating a healthy longevity index and developing a holistic model of how personal and environmental factors affect this index | Dr Yu Ho Yan |
| 2021.431 | Towards healthy ageing: Measurement of intrinsic capacity and its associated factors and health outcomes in community-dwelling older people | Dr Yu Ho Yan |
| 2020.583 | Use of technology to prevent and manage frailty and promote healthy ageing in Hong Kong | Dr. YU Ho Yan |
| 2010.606 | What determine influenza vacination in community-dwelling older people with medical risk factors for influenza-related complication | Prof Yu Doris, Sau-fung |
| 2019.097 | Using a vulnerability-stress model to predict expressed emotion among family caregivers of persons with dementia: A sequential explanatory mixed-method study | Prof. YU Doris Sau-Fung |
| 2014.003 | A Nurse-led End-of-life (EOL) Program for frail elders with end stage chronic diseases | Prof. YU Doris Sau Fung |
| 2015.516 | Enhancing the self-care of Chinese patients with chronic heart failure: Does an empowerment-based educational model make a difference? | Prof. YU Doris Sau Fung |
| 2016.063 | The effects of a strengths–based intervention based on salutogenic model on sense of coherence, coping, psychological status and health-related quality of life of family caregivers of persons with dementia | Prof. YU Doris Sau Fung |
| 2015.168 | The effects of Chair‐based dance exercise on physical, cognitive and psychological health among community‐dwelling older adults who reported fatigue |
Prof. YU Doris Sau Fung 余秀鳳 |
| 2017.272 | The effects and cost-effectiveness of a nurse-coordinated integrated heart failure- palliative care (NCI-HF-PC) model for patients with advanced heart failure: a randomised controlled trial |
Prof. YU Doris Sau Fung 余秀鳳 |
| 2017.090 | Unravelling positive aspect of caregiving in dementia: an integration of the Transactional Stress and Coping Model and Meaning Making Model | Prof. YU Doris Sau Fung |
| 2017.380 | The effects of strengths-based dyadic program on health-related quality of life (HRQL) of people with mild cognitive impairment and mild dementia in the community | Prof. YU Doris Sau Fung |
| 2019.046 | Frailty screening in elderly patients before and after hospitalization |
Prof. YU Doris Sau Fung 余秀鳳 |
| 2019.047 | New wine in old bottle: the effects of SUDOKU Mind Activation and Revitalizing Training (SMART) Program on cognitive function among people with mild cognitive impairment | Prof. YU Doris Sau Fung |
| 2012.463 | Effectiveness of a parent-targeted plant-based cooking and education programme on dietary pattern and cardiovascular health in overweight children | Dr Yu Chung wah Clare |
| 2019.717 | Exploring the level of physical activity for people diagnosed with severe mental illness in psychiatric day hospital (PDH) of Hong Kong and the relationship of physical activity and self-efficacy. |
Mr. YU Chun Lok 余俊樂 |
| 2008.211 | Endovascular Treatment of Adenomyosis with Transarterial Embolization with Lipiodol-Ethanol Mixture (LEM) | Dr Yu Chun Ho, Simon |
| 2019.261 | Percutaneous Lung Biopsy using Cone Beam CT with Virtual Guidance: a randomized control trial | Prof. YU Chun Ho |
| 2014.533 | A Phase III Clinical Trial of Intra-arterial TheraSphere® in the Treatment of Patients with Unresectable Hepatocellular Carcinoma (HCC) | Prof. YU Chun Ho |
| 2014.546 | Intravenous thrombolysis with or without early aspiration thrombectomy for acute anterior stroke with large thrombus burden -The INSTANT trial | Professor Yu Chun Ho |
| 2013.321 | Use of Colistin in the Intensive Care Units of Hong Kong: A Retrospective Observational Study. | Dr YU CHIN WING |
| 2011.381 | Registry for PaceMakers Offering Therapy Enhancement - EVIA | Professor Yu Cheuk-Man |
| 2012.356 | A comprehensive assessment of the cardiovascular effects of transcatheter renal sympathetic nerve denervation | Prof. YU Cheuk-Man |
| 2009.217 | Optimise CRT | Professor Yu Cheuk-Man |
| 2007.449 | Acute CRT for Dyssynchrony Management in DHF Patients | Professor Yu Cheuk-Man |
| 2008.114 | The Effect of Olmesartan Compared with Placebo on the Process of Left Ventricular Remodeling after Acute Myocardial Infarction | Professor Yu Cheuk-Man |
| 2013.244 | MADIT ASIA CARDIAC RESYNCHRONIZATION TRIAL | Prof Yu Cheuk-Man |
| 2010.479 | A randomized, double blind, placebo controlled, parallel group trial for assessing the clinical benefit of Dronedarone 400mg BID on top of standard therapy in patients with permanent atrial fibrillation and additional risk factors | Prof YU Cheuk-Man |
Page 8 of 264.